N. Noulin

发表

Dual Effects of p38 MAPK on TNF-Dependent Bronchoconstriction and TNF-Independent Neutrophil Recruitment in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome1

B. Ryffel, F. D. Di Padova, B. Vargaftig, 2005, The Journal of Immunology.

Respiratory Distress Syndrome Lipopolysaccharide-Induced Acute TNF-Independent Neutrophil Recruitment in TNF-Dependent Bronchoconstriction and Dual Effects of p 38 MAPK on

Isabelle, B. Ryffel, B. Vargaftig, 2005 .

Enhancement of Methacholine-Evoked Tracheal Contraction Induced by Bacterial Lipopolysaccharides Depends on Epithelium and Tumor Necrosis Factor

B. Ryffel, B. Vargaftig, T. Sécher, 2012, Journal of allergy.

Both Hemopoietic and Resident Cells Are Required for MyD88-Dependent Pulmonary Inflammatory Response to Inhaled Endotoxin1

B. Ryffel, B. Vargaftig, B. Schnyder, 2005, The Journal of Immunology.

Cigarette Smoke-Induced Pulmonary Inflammation Is TLR4/MyD88 and IL-1R1/MyD88 Signaling Dependent1

B. Ryffel, M. Le Bert, V. Lagente, 2008, The Journal of Immunology.

IL-1 R 1 / MyD 88 Signaling Dependent Inflammation Is TLR 4 / MyD 88 and Cigarette Smoke-Induced Pulmonary and Isabelle Couillin

B. Ryffel, V. Lagente, E. Boichot, 2007 .

Treatment with the P2X3-Receptor Antagonist Gefapixant for Acute Cough in Induced Viral Upper Respiratory Tract Infection: A Phase 2a, Randomized, Placebo-Controlled Trial

N. Noulin, Susan Lu, M. Kitt, 2022, Pulmonary Therapy.

T cell‐derived TNF down‐regulates acute airway response to endotoxin

S. Nedospasov, S. Grivennikov, B. Schnyder, 2007, European journal of immunology.

Treatment with the P2X3-Receptor Antagonist Gefapixant for Acute Cough in Induced Viral Upper Respiratory Tract Infection: A Phase 2a, Randomized, Placebo-Controlled Trial

N. Noulin, Susan Lu, M. Kitt, 2022, Pulmonary Therapy.

Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study

Rob Lambkin-Williams, A. Gilbert, H. Schuitemaker, 2021, The Journal of infectious diseases.

Radioresistant cells expressing TLR5 control the respiratory epithelium's innate immune responses to flagellin

S. Akira, J. Sirard, B. Ryffel, 2009, European journal of immunology.

Nonredundant roles of TIRAP and MyD88 in airway response to endotoxin, independent of TRIF, IL-1 and IL-18 pathways

S. Akira, B. Ryffel, B. Beutler, 2006, Laboratory Investigation.

Inflammatory Response to Inhaled Endotoxin Required for MyD 88-Dependent Pulmonary Both Hemopoietic and Resident Cells Are Isabelle

B. Ryffel, B. Vargaftig, B. Schnyder, 2005 .

Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge

J. Oxford, Rob Lambkin-Williams, A. Mann, 2014, PloS one.

Both Hemopoietic and Resident Cells Are Required for MyD88-Dependent Pulmonary Inflammatory Response to Inhaled Endotoxin1

B. Ryffel, B. Vargaftig, B. Schnyder, 2005, The Journal of Immunology.

Use of qualitative integrative cycler PCR (qicPCR) to identify optimal therapeutic dosing time-points in a Respiratory Syncytial Virus Human Viral Challenge Model (hVCM).

Rob Lambkin-Williams, C. Laxton, N. Noulin, 2015, Journal of virological methods.

LB6. EDP-938, a Novel RSV N-Inhibitor, Administered Once or Twice Daily Was Safe and Demonstrated Robust Antiviral and Clinical Efficacy in a Healthy Volunteer Challenge Study

E. Coakley, Kai Lin, K. Larson, 2019, Open Forum Infectious Diseases.

IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice.

S. Akira, B. Ryffel, V. Lagente, 2007, The Journal of clinical investigation.

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

A. Mann, N. Ferguson, C. Hopkins, 2022, Nature Medicine.

Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

Daniel J. Fullen, Rob Lambkin-Williams, A. Mann, 2016, PloS one.

Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

Daniel J. Fullen, Rob Lambkin-Williams, A. Mann, 2016, PloS one.

Toll‐like receptor and tumour necrosis factor dependent endotoxin‐induced acute lung injury

B. Ryffel, T. Sécher, V. Vasseur, 2007, International journal of experimental pathology.

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge

A. Mann, N. Ferguson, C. Hopkins, 2022 .

The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics

Rob Lambkin-Williams, A. Mann, A. Gilbert, 2018, Respiratory Research.

EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge.

N. Noulin, J. Mori, N. Adda, 2022, The New England journal of medicine.

The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process

Daniel J. Fullen, Rob Lambkin-Williams, A. Mann, 2018, BMC Research Notes.

The manufacturing of human viral challenge agents for use in clinical studies to accelerate the drug development process

Andrew P. Catchpole, Daniel J. Fullen, Nicolas Noulin, 2018, BMC Research Notes.

Radioresistant cells expressing TLR5 control the respiratory epithelium's innate immune responses to flagellin

S. Akira, J. Sirard, B. Ryffel, 2009, European journal of immunology.